Folic acid supplementation in a mouse model of diabetes in pregnancy alters insulin sensitivity in female mice and beta cell mass in offspring
The FASEB Journal · 2023
DOI: 10.1096/fj.202301491r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Ei-Xia Mussai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes, Gestational, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Natural Sciences and Engineering Research Council of Canada.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Epidemiological studies have reported discrepant findings on the relationship between folic acid intake during pregnancy and risk for gestational diabetes mellitus (GDM). To begin to understand how folic acid impacts metabolic health during pregnancy, we determined the effects of excess folic acid supplementation (5× recommendation) on maternal and fetal offspring metabolic health. Using a mouse (female C57BL/6J) model of diet‐induced diabetes in pregnancy (western diet) and control mice, we show that folic acid supplementation improved insulin sensitivity in the female mice fed the western diet and worsened insulin sensitivity in control mice. We found no unmetabolized folic acid in liver from supplemented mice suggesting the metabolic effects of folic acid supplementation are not due to unmetabolized folic acid. Male fetal (gestational day 18.5) offspring from folic acid supplemented dams (western and control) had greater beta cell mass and density than those from unsupplemented dams; this was not observed in female offspring. Differential sex‐specific hepatic gene expression profiles were observed in the fetal offspring from supplemented dams but this differed between western and controls. Our findings suggest that folic acid supplementation affects insulin sensitivity in female mice, but is dependent on their metabolic phenotype and has sex‐specific effects on offspring pancreas and liver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The University of British Columbia, Vancouver, British Columbia, Canada.
- BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
- Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Surgery, The University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Nutritional Sciences, Rutgers University, The State University of New Jersey, New Brunswick, New Jersey, USA.
- Baylor Scott and White Research Institute, Dallas, Texas, USA.
ORCID-Profile: Joshua W Miller, Teodoro Bottiglieri, Angela M Devlin
Förderung
- CIHR
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Mussai, E. X., Lofft, Z. A., Vanderkruk, B., Boonpattrawong, N., Miller, J. W., Smith, A., Bottiglieri, T., & Devlin, A. M. (2023). Folic acid supplementation in a mouse model of diabetes in pregnancy alters insulin sensitivity in female mice and beta cell mass in offspring. The FASEB Journal. https://doi.org/10.1096/fj.202301491r
Vancouver
Mussai EX, Lofft ZA, Vanderkruk B, Boonpattrawong N, Miller JW, Smith A, et al. Folic acid supplementation in a mouse model of diabetes in pregnancy alters insulin sensitivity in female mice and beta cell mass in offspring. The FASEB Journal. 2023. doi:10.1096/fj.202301491r
BibTeX
@article{Mussai2023,
author = {Mussai, Ei-Xia and Lofft, Zoe A and Vanderkruk, Ben and Boonpattrawong, Nicha and Miller, Joshua W and Smith, Andre and Bottiglieri, Teodoro and Devlin, Angela M},
title = {Folic acid supplementation in a mouse model of diabetes in pregnancy alters insulin sensitivity in female mice and beta cell mass in offspring},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202301491r}
}
EUVIMED